videoDetails![Video Thumbnail](https://english.cdn.zeenews.com/sites/default/files/styles/zm_700x400/public/2021/05/21/00000003_19.jpg?im=Resize=(400))
![Play icon](https://english.cdn.zeenews.com/static/public/icons/icon-vplay.svg)
Center's big decision regarding Black Fungus medicines, increase in production of drugs
![Video Thumbnail](https://english.cdn.zeenews.com/sites/default/files/styles/zm_700x400/public/2021/05/21/00000003_19.jpg?im=Resize=(400))
The Drug Controller General of India (DGCI) has approved five pharma companies to start manufacturing the anti-fungal drug Amphotericin B Liposomal Injection, the demand of which has increased in view of the rise in black fungus infection.